An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: A glasgow inflammation outcome study
Key mechanisms include: Angiogenesis Promotion : It up-regulates vascular endothelial growth factor (VEGF), enhancing blood vessel formation to improve nutrient delivery to damaged tissues.[6] Nitric Oxide (NO) Modulation : BPC-157 interacts with the NO system to support vasodilation and anti-thrombotic effects, aiding in wound healing and reducing inflammation.[7] Growth Hormone Receptor Enhancement : It increases expression of growth hormone receptors, facilitating cell proliferation and repair in muscles, tendons, and ligaments.[8] Cytoprotection and Anti-Inflammatory Effects : By protecting cells from toxins (e.g., alcohol, NSAIDs) and modulating inflammatory pathways, it maintains tissue integrity, particularly in the GI tract and central nervous system (CNS).[9] Neuroprotective Interactions : It influences dopamine and glutamate systems, potentially mitigating brain damage from trauma or ischemia.[10] These actions make BPC-157 a versatile agent in regenerative medicine, often compared to "Wolverine-like" healing in anecdotal reports from users
However, a specific GHRH antagonist blunted the GH response to L-arginine, an observation that supports the notion that L-arginine also acts through stimulation of GHRH secretion (497)
Mutant p53 as a guardian of the cancer cell
